Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

NCT02626754 is registered in ClinicalTrials.gov with vghtpe user as lead sponsor.

NCT NCT02626754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02626754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population
Lead sponsor
vghtpe user
Phase
Phase 2
Overall status
Terminated
Start date
August 12, 2015
Completion date
January 2, 2018
Enrollment
13 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma